Drug Shortage Report for IMITREX

Last updated on 2017-05-26 History
Report ID 5841
Drug Identification Number 02230420
Brand name IMITREX NASAL SPRAY
Common or Proper name Sumatriptan nasal spray
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 20MG
Dosage form(s) SPRAY
Route of administration NASAL
Packaging size 2's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-16
Estimated end date 2017-05-26
Actual end date 2017-05-25
Shortage status Resolved
Updated date 2017-05-26
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2017-05-26 English Compare
v23 2017-05-25 French Compare
v22 2017-05-25 English Compare
v21 2017-05-25 English Compare
v20 2017-05-25 French Compare
v19 2017-05-25 English Compare
v18 2017-05-25 English Compare
v17 2017-05-25 English Compare
v16 2017-05-25 English Compare
v15 2017-05-25 English Compare
v14 2017-05-25 English Compare
v13 2017-05-25 English Compare
v12 2017-05-25 English Compare
v11 2017-05-16 English Compare
v10 2017-05-10 French Compare
v9 2017-05-10 English Compare
v8 2017-05-09 English Compare
v7 2017-04-26 French Compare
v6 2017-04-26 English Compare
v5 2017-04-25 English Compare

Showing 1 to 20 of 24